Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Chamberlain, Connie S ^a   Leiferman, Ellen M ^a   Frisch, Kayt E ^b   Brickson, Stacey L ^a   Murphy, William L ^a,b   Baer, Geoffrey S ^a   Vanderby, Ray ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 16; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; KNEE LIGAMENT INJURY; MACROPHAGE; MALE; MYOFIBROBLAST; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SINGLE DRUG DOSE; TISSUE MICROARRAY; UPREGULATION;

ANIMALS; BIOMECHANICAL PHENOMENA; CICATRIX; COLLAGEN; COLLATERAL LIGAMENTS; FIBROSIS; GENE EXPRESSION REGULATION; INTERLEUKINS; MACROPHAGES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-1;

EID: 84880977964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071631     Document Type: Article

References (35)

1. Chamberlain CS, Brounts SH, Sterken DG, Rolnick KI, Baer GS, et al. (2011) Gene profiling of the rat medial collateral ligament during early healing using microarray analysis. J Appl Physiol 111: 552-565.
2. Chamberlain CS, Crowley EM, Kobayashi H, Eliceiri KW, Vanderby R, (2011) Quantification of collagen organization and extracellular matrix factors within the healing ligament. Microsc Microanal 17: 779-787.
3. Chamberlain CS, Crowley E, Vanderby R, (2009) The spatio-temporal dynamics of ligament healing. Wound Repair Regen 17: 206-215.
4. Werner S, Grose R, (2003) Regulation of wound healing by growth factors and cytokines. Physiological Reviews 83: 835-870.
5. Mirza R, DiPietro LA, Koh TJ, (2009) Selective and Specific Macrophage Ablation Is Detrimental to Wound Healing in Mice. American Journal of Pathology 175: 2454-2462.
6. Bosschaerts T, Guilliams M, Stijlemans B, Morias Y, Engel D, et al. (2010) Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog 6: e1001045.
7. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG, (2003) TN/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
8. Nathan C, Ding AH, (2010) Nonresolving Inflammation. Cell 140: 871-882.
9. Wynn TA, (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nature Reviews Immunology 4: 583-594.
10. Xiao W, Hong H, Kawakami Y, Lowell CA, Kawakami T, (2008) Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. J Clin Invest 118: 924-934.
11. Biswas SK, Mantovani A, (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
12. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, et al. (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204: 1057-1069.
13. Puehler W, Rittner HL, Mousa SA, Brack A, Krause H, et al. (2006) Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation. Neuroscience 141: 989-998.
14. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, et al. (1982) Interleukin-1 Activity in the Synovial-Fluid of Patients with Rheumatoid-Arthritis. Rheumatology International 2: 49-53.
15. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL, (1983) Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 26: 975-983.
16. Pettipher ER, Higgs GA, Henderson B, (1986) Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A 83: 8749-8753.
17. van de Loo AA, van den Berg WB, (1990) Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 49: 238-245.
18. Gasse P, Mary C, Guenon I, Noulin N, Charron S, et al. (2007) IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 117: 3786-3799.
19. Kuek A, Hazleman BL, Ostor AJ, (2007) Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 83: 251-260.
20. Nixon R, Bansback N, Brennan A, (2007) The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons. Rheumatology 46: 1140-1147.
21. Molto A, Olive A, (2010) Anti-IL-1 molecules: New comers and new indications. Joint Bone Spine 77: 102-107.
22. Nigrovic PA, Mannion M, Prince FHM, Zeft A, Rabinovich CE, et al. (2011) Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series. Arthritis Rheum 63: 545-555.
23. Zhang B, Hu J, Man C, Zhu S, (2011) Effect of intra-articular administration of interleukin 1 receptor antagonist on cartilage repair in temporomandibular joint. J Craniofac Surg 22: 711-714.
24. Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, et al. (2008) Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117: 2662-2669.
25. Kim DH, Lee SH, Kim KT, Yu SD, (2010) Association of interleukin-1 receptor antagonist gene polymorphism with response to conservative treatment of lumbar herniated nucleus pulposus. Spine (Phila Pa 1976) 35: 1527-1531.
26. Dinarello CA, (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
27. Arend WP, (1990) Interleukin-1 receptor antagonist: discovery, structure and properties. Prog Growth Factor Res 2: 193-205.
28. Hanke ML, Angle A, Kielian T, (2012) MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection. PLoS One 7: e42476.
29. Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW, (2001) Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 93: 781-785.
30. Naldini A, Carraro F, (2005) Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 4: 3-8.
31. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J, (2001) Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536.
32. Ko JY, Wang FS, Huang HY, Wang CJ, Tseng SL, et al. (2008) Increased IL-1 beta expression and myofibroblast recruitment in subacromial bursa is associated with rotator cuff lesions with shoulder stiffness. Journal of Orthopaedic Research 26: 1090-1097.
33. Chaudhuri V, Zhou L, Karasek M, (2007) Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J Cutan Pathol 34: 146-153.
34. Chamberlain CS, Leiferman EM, Frisch KE, Wang S, Yang X, et al. (2011) The influence of macrophage depletion on ligament healing. Connect Tissue Res 52: 203-211.
35. Arend WP, Welgus HG, Thompson RC, Eisenberg SP, (1990) Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85: 1694-1697.